Consumers spent 3.9 percent more from Nov. 1 to Dec. 21 this year compared with last year, according to a Mastercard report on holiday spending.
Category: MasterCard Inc
-
Shoppers, Drawn by Steep Discounts, Power Through Black Friday
Data on spending this week shows that consumers are shopping big for the holidays despite inflation and economic worries.
-
Mastercard Agrees to Settle Pay Discrimination Suit for $26 Million
The complaint accuses the company of underpaying female, Black and Hispanic employees compared with their male and white counterparts.
-
As Retailers Offered Holiday Discounts, Shoppers Showed Up
Total spending from Nov. 1 through Dec. 24 rose 3.8 percent, data released by Mastercard SpendingPulse showed.
-
Are Travel Loyalty Programs at Risk?
A new agreement by Visa and Mastercard to reduce fees charged to merchants may drain the lucrative rewards that grant free travel to many credit card users.
-
The Fallout From the Credit Card Swipe Fee Fight
A proposed settlement between Visa and Mastercard and merchants on swipe fees promises savings, but it may also alter the economics of premium credit cards.
-
How Washington May Approach the Capital One-Discover Deal
Regulators have been tough on big financial mergers, though there are nuances in Capital One’s $35.3 billion takeover bid for Discover.
-
Holiday Spending Increased, Defying Fears of a Decline
While the pace of growth slowed, spending stayed strong because of robust job growth and strong wage gains.
-
Is the Holiday Shopping Season Going to Be a Success? The Answer Is Murky.
Black Friday weekend had a decent turnout for retailers, but it’s unclear if the rest of the season will deliver for the industry.
-
Travel Rewards Cards: How to Maximize Points, Perks and Miles
The range of perks you can earn is almost as bewildering as the rules to get them are. Here’s how to compare cards and get the most out of the ones you have.
-
Mastercard Moves to Stop Use of Debit Cards at Cannabis Shops
The decision places more strain on the cannabis industry, which largely operates with cash only, and is not uniformly regulated across the United States. The drug is still illegal on the federal level.